Enhancer RNAs contribute to genome reprogramming driven by a GATA3 noncoding variant in leukaemia

Area of Science:

• Genetics
• Molecular Biology
• Oncology

Background:

• Philadelphia chromosome-like B-acute lymphoblastic leukemia (Ph-like B-ALL) pathogenesis involves genetic alterations.
• The GATA3 noncoding variant rs3824662 is linked to Ph-like B-ALL, causing chromatin reorganization and gene dysregulation, including CRLF2 overexpression.

Purpose of the Study:

• To investigate the role of enhancer RNAs (eRNAs) near the GATA3 locus in regulating CRLF2 expression.
• To explore the cooperative function of the GATA3 variant rs3824662 and eRNAs in Ph-like B-ALL.

Main Methods:

• Analysis of GATA3 binding regions and chromatin accessibility.
• Correlation analysis between eRNA expression and CRLF2 expression.
• Quantification of eRNA_G3 and GATA3 variant rs3824662 in Ph-like ALL cases.

Main Results:

• eRNA_G3 expression was positively correlated with CRLF2 expression.
• eRNA_G3 was significantly upregulated in Ph-like ALL cases with the GATA3 rs3824662 variant.
• The GATA3 variant rs3824662 is associated with altered chromatin landscape and increased accessibility of GATA3 binding regions.

Conclusions:

• eRNA_G3 may play a regulatory role in CRLF2 expression in Ph-like B-ALL.
• The GATA3 variant rs3824662 and eRNAs may cooperatively regulate GATA3 and CRLF2 expression in Ph-like ALL.